Nilanjan Adhikari

43PUBLICATIONS
12CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsHaematological tumoursCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jan 07, 2026
Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions.

Suvankar Banerjee, Nilanjan Adhikari, Balaram Ghosh

|Oct 29, 2025
PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies.

Ambati Himaja, Debojyoti Halder, Suvankar Banerjee

|Sep 26, 2025
Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis.

Suvankar Banerjee, Sandip Kumar Baidya, Tarun Jha

|Nov 26, 2024
Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors.

Goverdhan Lanka, Suvankar Banerjee, Sanjeev Regula

|Sep 05, 2024
Biphenylsulfonamides as effective MMP-2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis.

Sandip K Baidya, Tarun Patel, Ambati Himaja

|Aug 28, 2024
Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis.

S K Baidya, S Banerjee, B Ghosh

Pageof 8

Frequent Collaborators

40 joint publications

Tarun Jha

20 joint publications

Sk Abdul Amin

19 joint publications

Suvankar Banerjee

19 joint publications

Balaram Ghosh